Our data, combined with previous results (25, 59, –, 61) indicating that HRD1 mediates SIRT2, suggested that targeting the regulation of SIRT2 by repressing HRD1 expression may be an important method for NSCLC treatment. The gene discussed is SIRT2; the disease is non-small cell lung carcinoma.